Source: Eur Respir J, 58 (6) 2101890; 10.1183/13993003.01890-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Ana I. Hernandez Cordero, Chen Xi Yang, Stephen Milne, Xuan Li, Zsuzsanna Hollander, Virginia Chen, Raymond Ng, Scott J. Tebbutt, Janice M. Leung, Don D. Sin. Epigenetic blood biomarkers of ageing and mortality in COPD. Eur Respir J, 58 (6) 2101890; 10.1183/13993003.01890-2021

Member's Comments

No comment yet.

Related content which might interest you: Metabolic changes in lung ageing and COPD Source: International Congress 2019 – Metabolic alterations in lung ageing and disease Year: 2019 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 DNA-estimated ageing markers are associated with COPD Source: International Congress 2018 – Role of omics in population studies Year: 2018 Transcriptomic and epigenetic changes in the lung of patients with severe COPD Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Blood biomarkers in asthma and COPD Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Comorbidities and the ageing lung Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course Source: Eur Respir J, 53 (4) 1801795; 10.1183/13993003.01795-2018 Year: 2019 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Genetic risk for covid-19 outcomes in COPD Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Accelerated ageing in COPD Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD Source: Eur Respir J 2014; 43: 951-953 Year: 2014 Is childhood asthma associated with biological aging markers? Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017